BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7915698)

  • 1. [Arterial hypertension in Cushing's disease: the 24-hour pressure profile without and during treatment with beta-blockers or cyproheptadine].
    Prattichizzo FA
    G Ital Cardiol; 1994 May; 24(5):533-8. PubMed ID: 7915698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the hypothalamo-pituitary-adrenal axis in the control of circadian blood pressure rhythm.
    Munakata M; Imai Y; Abe K; Sasaki S; Minami N; Sekino H; Yoshinaga K
    J Hypertens Suppl; 1988 Dec; 6(4):S44-6. PubMed ID: 3241233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for differential control of cardiovascular variables by glucocorticoids.
    Panarelli M; Terzolo M; Piovesan A; Osella G; Paccotti P; Pinna G; Angeli A
    Ann Ital Med Int; 1990; 5(1):18-25. PubMed ID: 2206764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian blood pressure variations under different pathophysiological conditions.
    Imai Y; Abe K; Munakata M; Sakuma H; Hashimoto J; Imai K; Sekino H; Yoshinaga K
    J Hypertens Suppl; 1990 Dec; 8(7):S125-32. PubMed ID: 2095380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure.
    Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G
    Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol.
    Saito K; Furuta Y; Sano H; Yokoyama M; Fukuzaki H
    Clin Ther; 1994; 16(2):181-90. PubMed ID: 8062314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.
    Zelinka T; Strauch B; Pecen L; Widimský J
    J Hum Hypertens; 2004 Feb; 18(2):107-11. PubMed ID: 14730325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension.
    Uzu T; Kimura G; Yamauchi A; Kanasaki M; Isshiki K; Araki S; Sugiomoto T; Nishio Y; Maegawa H; Koya D; Haneda M; Kashiwagi A
    J Hypertens; 2006 Aug; 24(8):1627-32. PubMed ID: 16877966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily variation of blood pressure in patients with Cushing's syndrome.
    Imai Y; Abe K; Sasaki S; Minami N; Nihei M; Munakata M; Sekino H; Yoshinaga K
    Tohoku J Exp Med; 1987 Sep; 153(1):67-74. PubMed ID: 3672505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Profiles and variations of ambulatory arterial pressure in treated and untreated hypertensive patients].
    Jacot des Combes B; Waeber B; Porchet M; Biollaz J; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(10):371-2. PubMed ID: 6133349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Betaxolol treatment of hypertension in postmenopausal women].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Metel'skaia VA
    Ter Arkh; 1999; 71(6):67-9. PubMed ID: 10420462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cushing's disease with cypropheptadine (author's transl)].
    Michelsen H; Contreras P; Bradford I; Rojas A
    Rev Med Chil; 1977 Jun; 105(6):380-3. PubMed ID: 331429
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered circadian blood pressure rhythm in patients with Cushing's syndrome.
    Imai Y; Abe K; Sasaki S; Minami N; Nihei M; Munakata M; Murakami O; Matsue K; Sekino H; Miura Y
    Hypertension; 1988 Jul; 12(1):11-9. PubMed ID: 3397172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [24-hour automated recording of blood pressure in the diagnosis and treatment of arterial hypertension].
    Kabat M; Puciłowska B; Paschalis-Purtak K
    Kardiol Pol; 1992 Sep; 37(9):165-70. PubMed ID: 1479775
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure responses to phenylephrine infusions in subjects with Cushing's syndrome.
    McKnight JA; Rooney DP; Whitehead H; Atkinson AB
    J Hum Hypertens; 1995 Oct; 9(10):855-8. PubMed ID: 8576903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nisoldipine coat-core and heart rate response during treatment of hypertension.
    Zannad F
    Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.